The HLA-Cw*06 allele and - 21149 G/T polymorphism of extrapituitary promoter of PRL gene as a possible common genetic predisposing factors to psoriasis vulgaris and psoriatic arthritis in Czech population

Rheumatology International

Volumn 33, Issue 4, 2013, Pages 913-919

  Cibulova, Anna ^a   Zajacova, Marta ^a   Fojtikova, Marketa ^b   Stolfa, Jiri ^b   Sedova, Liliana ^b   Cejkova, Pavlina ^a   Lippert, Jan ^c   Arenberger, Petr ^c   Cerna, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Age of psoriasis onset; HLA Cw; Prolactin; Psoriasis vulgaris; Psoriatic arthritis

Indexed keywords

GENOMIC DNA; HLA C ANTIGEN; HLA CW ANTIGEN; PROLACTIN; UNCLASSIFIED DRUG; HLA C*06 ANTIGEN; HLA-C*06 ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROLACTIN RELEASE; PROMOTER REGION; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; CAUCASIAN; GENE FREQUENCY; GENETIC ASSOCIATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ARTHRITIS, PSORIATIC; CZECH REPUBLIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLACTIN; PROMOTER REGIONS, GENETIC; PSORIASIS;

EID: 84886607806     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2472-7     Document Type: Article

References (43)

1. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14-ii17
2. Alenius GM, Jidell E, Nordmark L, RantapääDahlqvist S (2002) Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden. Clin Rheumatol 21: 357-362
3. Elkayam O, Ophir J, Yaron M, Caspi D (2000) Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 19: 301-305
4. Sibilia J (2006) Psoriasis: skin and joints, same fight? J Eur Acad Dermatol Venereol 20(Suppl 2): 56-72
5. Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Río J, Rodriguez Pérez A, Brautbar C, López-Larrea C (1999) The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 42: 1010-1016
6. Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41: 1103-1110
7. Gudjónsson JE, Kárason A, Antonsdó ttir AA, Rúnarsdóttir EH, Gulcher JR, Stefánsson K, Valdimarsson H (2002) HLA-Cw6- positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. J Invest Dermatol 118: 362-365
8. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13: 450-456
9. Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, Yhr M (1995) Age at onset and different types of psoriasis. Br J Dermatol 133: 768-773
10. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT (2006) Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 78: 827-851
11. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, Barker JN (1997) Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 6: 813-820
12. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, Wilson MJ, Trowsdale J, Gladman D, Carrington M (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169: 2818-2822
13. Valdimarsson H (2007) The genetic basis of psoriasis. Clin Dermatol 25: 563-567
14. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66: 1833-1844
15. Karason A, Gudjonsson JE, Upmanyu R, Antonsdottir AA, Hauksson VB, Runasdottir EH, Jonsson HH, Gudbjartsson DF, Frigge ML, Kong A, Stefansson K, Valdimarsson H, Gulcher JR (2003) A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 72: 125-131
16. Grubić Z, Perić P, Eeèuk-Jelicić E, Zunec R, Stingl K, Curković B, Kerhin-Brkljacić V (2004) The MICA-A4 triplet repeats polymorphism in the transmembrane region confers additional risk for development of psoriatic arthritis in the Croatian population. Eur J Immunogenet 31: 93-98
17. Ho PY, Barton A, Worthington J, Thomson W, Silman AJ, Bruce IN (2007) HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis 66: 807-811
18. Fojtikova M, Stolfa J, Novota P, Cejkova P, Dostal C, Cerna M (2009) HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population. Rheumatol Int 29: 1293-1299
19. Matalka KZ (2003) Prolactin enhances production of interferongamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner. Cytokine 21: 187-194
20. Kanda N, Watanabe S (2007) Prolactin enhances interferongamma- induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148:2317- 2325
21. McMurray RW (2001) Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum 31: 21-32
22. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17: 639-669
23. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8: 25-30
24. Moszkorzova L, Lacinova Z, Marek J, Musilova L, Dohnalova A, Dostal C (2002) Hyperprolactinemia in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20: 807-812
25. Leanos-Miranda A, Cardenas-Mondragon G (2006) Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology 45: 97-101
26. Fojtíková M, Tomasová Studýnková J, Filková M, Lacinová Z, Gatterová J, Pavelka K, Vencovský J, Senolt L (2010) Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage. Clin Exp Rheumatol 28: 849-854
27. Dilme-Carreras E, Martin-Ezquerra G, Sanchez-Regana M, Umbert-Millet P (2011) Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 36: 29-32
28. El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE (2011) Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol 50: 693-696
29. Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H (2011) Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem 44: 1209-1213
30. Berwaer M, Martial JA, Davis JR (1994) Characterization of an upstream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 8: 635-642
31. Reem GH, Ray DW, Davis JRE (1999) The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP. J Mol Endocrinol 22: 285-292
32. Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, Ollier WE, Worthington J, Davis JR (2001) Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum 44: 2358-2366
33. Stevens A, Ray DW, Worthington J, Davis JR (2001) Polymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10: 676-683
34. Lee YC, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L, Padyukov L, Costenbader KH, Seielstad M, Graham RR, Klareskog L, Gregersen PK, Plenge RM, Karlson EW (2009) The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthritis Rheum 60: 1250-1254
35. Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3: 55-78
36. Mallon E, Bunce M, Wojnarowska F, Welsh K (1997) HLACw* 0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics. J Invest Dermatol 109: 183-186
37. Gudjonsson JE, Karason A, Runarsdottir EH, Antonsdottir AA, Hauksson VB, Jónsson HH, Gulcher J, Stefansson K, Valdimarsson H (2006) Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126: 740-745
38. Sczcerkowska Dobosz A, Rebala K, Szczerkowska Z, Nedoszytko B (2005) HLA-C locus alleles distribution in patients from northern Poland with psoriatic arthritis: preliminary report. Int J Immunogenet 32: 389-391
39. Gladman DD, Cheung C, Ng CM, Wade JA (1999) HLA-C locus alleles in patients with psoriatic arthritis (PsA). Hum Immunol 60: 259-261
40. Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS, Bradburn P, Thomson W, Silman AJ, Bruce IN (2008) Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriasis arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis 67: 677-682
41. Queiro R, Torre JC, González S, López-Larrea C, Tinturé T, López-Lagunas I (2003) HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. J Rheumatol 30: 505-507
42. Queiro R, Gonzales S, Lopez-Larrea C, Alperi M, Sarasqueta C, Riestra JL, Ballina J (2006) HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis. Arthritis Res Ther 8:R185
43. Gellersen B, Kempf R, Telgmann R, DiMattia GE (1994) Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 8: 356-357